Join us in person at AMCP 2023 or virtually at home for this 1.5-hour live, ACPE-certified satellite symposium on examining advances in ovarian cancer and strategies for promoting optimal and equitable care. This interactive event features expert perspectives on the evolving role of biomarkers for targeted therapy. Bring your questions for the question and answer session with the expert faculty.
Pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with ovarian cancer and pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice and managed care.
SVP, Clinical Strategy and Growth
Oncology Clinical Pharmacist
The University of Kansas Health System
Kansas City, Kansas
Examining Advances in Ovarian Cancer and Strategies to Promote Optimal and Equitable Care
There are no fees required to participate in this activity.
Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact email@example.com prior to the live event.
The goal of this activity is to improve the knowledge and competence of learners in the management of patients with ovarian cancer, including those with treatment-naive and relapsed ovarian cancer.
This activity is intended for pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with ovarian cancer and pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice and managed care.
Upon completion of this activity, participants should be able to:
This activity is jointly provided by ProCE, LLC and Clinical Care Options, LLC. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-23-006-L01-P has been assigned to this live application-based activity (initial release date 03/22/2023). This activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.
ProCE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC.
Supported by educational grants from AstraZeneca, GSK, Immunogen, Inc., Merck Sharp & Dohme LLC, and Novocure, Inc.